PATIENT INFORMATION LEAFLET
LOSARTAN KORHISPANA 50 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine.
|
Contents of the pack:
Additional information
Losartan belongs to a group of medicines called angiotensin II receptor antagonists.
Angiotensin II is a substance produced in the body that binds to receptors in blood vessels, causing them to narrow. This leads to an increase in blood pressure. Losartan prevents angiotensin II from binding to these receptors, which causes the blood vessels to relax, resulting in a decrease in blood pressure. Losartan reduces the worsening of kidney function in patients with high blood pressure and type 2 diabetes.
Losartan Korhispana is used:
Do not take Losartan Korhispana
Be particularly cautious with Losartan Korhispana
Tell your doctor if you are pregnant (or if you think you might be). Your doctor will generally advise you to stop taking Losartan Korhispana before becoming pregnant or as soon as you know you are pregnant and will recommend that you take another medication instead of Losartan Korhispana. It is not recommended to use Losartan Korhispana at the start of pregnancy, and in no case should it be administered after the third month of pregnancy, as it may cause serious harm to your baby when administered from that time on (see section on Pregnancy).
Before taking Losartan Korhispana, it is essential that you inform your doctor:
Your doctor may monitor your kidney function, blood pressure, and blood electrolyte levels (e.g., potassium) at regular intervals.
See also the information under the heading “Do not take Losartan Korhispana”.
Use of other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or might take other medications, including those obtained without a prescription, herbal medicines, and natural products.
While being treated with Losartan Korhispana, be particularly cautious if you take any of the following medications:
Your doctor may need to adjust your dose and/or take other precautions:
If you are taking an angiotensin-converting enzyme inhibitor (ACE inhibitor) or aliskiren (see also the information under the headings “Do not take Losartan Korhispana” and “Be particularly cautious with Losartan Korhispana”).
If your kidney function is impaired, concomitant use of these medications may worsen kidney function.
Medications containing lithium should not be used in combination with losartan without your doctor's careful monitoring. It may be appropriate to take special precautions (e.g., blood tests).
Taking Losartan Korhispana with food and drinks
Losartan can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You should inform your doctor if you are pregnant (or if you think you might be). Your doctor will generally advise you to stop taking Losartan Korhispana before becoming pregnant or as soon as you know you are pregnant and will recommend that you take another medication instead of Losartan Korhispana. It is not recommended to use Losartan Korhispana at the start of pregnancy, and in no case should it be administered after the third month of pregnancy, as it may cause serious harm to your baby when administered from that time on.
Breastfeeding
Tell your doctor if you are breastfeeding or plan to start breastfeeding. It is not recommended to use Losartan Korhispana during breastfeeding, and your doctor will choose another treatment for you if you want to breastfeed, especially if your baby is newborn or premature.
Consult your doctor or pharmacist before using any medication.
Use in children and adolescents
Losartan has been studied in children. For more information, talk to your doctor.
Driving and using machines
No studies have been conducted on the effects on the ability to drive and use machines.
It is unlikely that Losartan Korhispana will affect your ability to drive or use machines. However, as with many medications used to treat high blood pressure, losartan may cause dizziness or drowsiness in some people. If you experience dizziness or drowsiness, consult your doctor before performing these activities.
Important information about some of the ingredients of Losartan Korhispana:
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the instructions for administration of Losartan Korhispana indicated by your doctor. Your doctor will decide the appropriate dose of Losartan Korhispana, depending on your condition and whether you are taking other medications. It is essential to continue taking Losartan Korhispana as prescribed by your doctor to maintain constant control of your blood pressure.
Patient with high blood pressure
Normally, treatment starts with 50 mg of losartan (one Losartan Korhispana 50 mg tablet) once a day. The maximum blood pressure-lowering effect is achieved within 3-6 weeks of starting treatment. After that, in some patients, the dose may be increased to 100 mg of losartan (two Losartan Korhispana 50 mg tablets) once a day.
If you think the effect of Losartan Korhispana is too strong or too weak, please inform your doctor or pharmacist.
Patient with high blood pressure and type 2 diabetes
Normally, treatment starts with 50 mg of losartan (one Losartan Korhispana 50 mg tablet) once a day. After that, the dose may be increased to 100 mg of losartan (two Losartan Korhispana 50 mg tablets) once a day, depending on your blood pressure response.
Losartan tablets can be administered with other medications that lower blood pressure (e.g., diuretics, calcium antagonists, alpha or beta blockers, and centrally acting agents), as well as with insulin and other medications frequently used to lower blood glucose levels (e.g., sulfonylureas, glitazones, and glucosidase inhibitors).
Patient with heart failure
Normally, treatment starts with 12.5 mg of losartan once a day. Normally, the dose is gradually increased weekly (i.e., 12.5 mg per day during the first week, 25 mg per day during the second week, and 50 mg per day during the third week) to a maintenance dose of 50 mg of losartan (one Losartan Korhispana 50 mg tablet) once a day, depending on your condition.
In the treatment of heart failure, losartan is usually combined with a diuretic (a medication that increases the amount of water that passes through your kidneys) and/or digitalis (a medication that helps your heart be stronger and more efficient) and/or a beta-blocker.
Dosage in special patient groups
Your doctor may recommend a lower dose, especially when starting treatment in certain patients, such as those treated with high-dose diuretics, patients with liver failure, or patients over 75 years old. It is not recommended to use losartan in patients with severe liver failure (see section “Do not take Losartan Korhispana”).
Administration
The tablets should be taken with a glass of water. You should try to take your daily dose at approximately the same time each day. It is essential to continue taking Losartan Korhispana until your doctor tells you to stop.
If you take more Losartan Korhispana than you should
If you accidentally take too many tablets or if a child swallows some, contact your doctor immediately. The symptoms of overdose are low blood pressure, increased heart rate, and possibly decreased heart rate.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or nurse immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Losartan Korhispana
If you accidentally miss a dose, simply take the next dose as usual.
Do not take a double dose to make up for the missed tablet.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, Losartan Korhispana can cause side effects, although not everyone gets them.
If you experience the following, stop taking the losartan tablets and inform your doctor immediately or go to the emergency department of your nearest hospital:
A severe allergic reaction (skin rash, itching, swelling of the face, lips, mouth, or throat that can cause difficulty swallowing or breathing).
This is a serious but rare side effect, affecting more than 1 patient in 10,000 but less than 1 patient in 1,000. You may need urgent medical attention or hospitalization.
Medication side effects are classified as follows:
very common:affect more than 1 in 10 patients
common:affect 1 to 10 patients in 100
uncommon:affect 1 to 10 patients in 1,000
rare:affect 1 to 10 patients in 10,000
very rare:affect less than 1 patient in 10,000
unknown:frequency cannot be estimated from available data
The following side effects have been reported with Losartan Korhispana:
Common:
Uncommon:
Rare:
Unknown:
Reporting of side effects:
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible that they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep out of the reach and sight of children.
Do not use Losartan Korhispana after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.
Do not store above 25°C.
Store Losartan Korhispana in its original packaging.
Do not open the blister pack until you are ready to take the medication.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medications at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medications. This will help protect the environment.
Composition of Losartán Korhispana
The active ingredient of Losartán Korhispana is losartan potassium. Each Losartán Korhispana 50 mg film-coated tablet contains 50 mg of losartan potassium.
Losartán Korhispana 50 mg contains potassium in the following amount: 4.24 mg (0.108mEq).
Appearance of the Product and Packaging Contents
Losartán Korhispana is supplied as round, white, film-coated tablets with a score line. The tablets can be divided into two equal halves.
Losartán Korhispana is supplied in the following package sizes:
Aluminum-PVC/PE/PVDC blister pack, in packages of 28 tablets.
Marketing Authorization Holder and Manufacturer: | |
Marketing Authorization Holder: KORHISPANA, S.L. Ctra. Castellvell, 24 43206 Reus (Tarragona) Spain | Manufacturer: KERN PHARMA, S.L. Polígono Industrial Colón II Venus, 72 08228 Terrassa (Barcelona) Spain |
This leaflet was approved in February 2025
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/